IL33 and experimental autoimmune encephalomyelitis: Additionally, it has been shown in experimental autoimmune encephalomyelitis that IL-33 is capable of diminishing the secretion of inflammatory cytokines such as IFN-γ (Th1) and IL-17 (Th17) [30].